| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 THBS3 FBN2 LTBP1 LTBP2 MUC5AC MUC6 FBN3 | 1.05e-11 | 188 | 100 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | Notch binding | 5.22e-11 | 27 | 100 | 7 | GO:0005112 | |
| GeneOntologyMolecularFunction | calcium ion binding | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 1.08e-10 | 749 | 100 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 KRT83 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 THBS3 FBN2 JAG1 LTBP1 LTBP2 MUC5AC MUC6 FBN3 | 8.63e-06 | 891 | 100 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.51e-05 | 16 | 100 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 6.80e-05 | 85 | 100 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 6.80e-05 | 85 | 100 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 7.88e-05 | 17 | 100 | 3 | GO:0000900 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.52e-04 | 21 | 100 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | integrin binding | 2.51e-04 | 175 | 100 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.17e-04 | 65 | 100 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.27e-04 | 27 | 100 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | microfibril binding | 3.68e-04 | 6 | 100 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | heparin binding | 4.12e-04 | 192 | 100 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 8.79e-04 | 85 | 100 | 4 | GO:0008135 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.20e-03 | 323 | 100 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.59e-03 | 12 | 100 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.59e-03 | 12 | 100 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.17e-03 | 14 | 100 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.30e-03 | 268 | 100 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.43e-03 | 112 | 100 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 2.50e-03 | 15 | 100 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.13e-03 | 599 | 100 | 9 | GO:0050839 | |
| GeneOntologyBiologicalProcess | axon guidance | EPHA6 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 CELSR3 NRXN1 LRP1 NOTCH1 EPHA10 | 1.22e-08 | 285 | 99 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHA6 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 CELSR3 NRXN1 LRP1 NOTCH1 EPHA10 | 1.27e-08 | 286 | 99 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | axonogenesis | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 CELSR3 NRXN1 LRP1 LRP4 NOTCH1 EPHA10 | 8.07e-08 | 566 | 99 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 9.26e-08 | 748 | 99 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.59e-07 | 84 | 99 | 7 | GO:1903053 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 2.49e-07 | 802 | 99 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 3.34e-07 | 819 | 99 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 3.77e-07 | 826 | 99 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | TRIM46 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 CELSR3 NRXN1 LRP1 LRP4 NOTCH1 EPHA10 | 4.06e-07 | 642 | 99 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TRIM46 PLOD3 EPHA6 LAMA1 ADGRB1 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 LRP1 LRP4 AFDN NOTCH1 EPHA10 NOTCH4 ARAP1 | 8.17e-07 | 1194 | 99 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.50e-06 | 41 | 99 | 5 | GO:0035909 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 MPV17 PLOD3 EFEMP2 LAMA1 LAMA2 LAMB2 ADAM10 TIE1 LRP1 NOTCH1 | 1.97e-06 | 377 | 99 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 MPV17 PLOD3 EFEMP2 LAMA1 LAMA2 LAMB2 ADAM10 TIE1 LRP1 NOTCH1 | 2.02e-06 | 378 | 99 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 MPV17 PLOD3 EFEMP2 LAMA1 LAMA2 LAMB2 ADAM10 TIE1 LRP1 NOTCH1 | 2.07e-06 | 379 | 99 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 2.12e-06 | 6 | 99 | 3 | GO:0002085 | |
| GeneOntologyBiologicalProcess | aorta development | 2.37e-06 | 80 | 99 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | astrocyte development | 3.01e-06 | 47 | 99 | 5 | GO:0014002 | |
| GeneOntologyBiologicalProcess | artery development | 3.60e-06 | 133 | 99 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | neuron development | TRIM46 IFT140 EPHA6 LAMA1 ADGRB1 CPEB3 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 SCARB2 TENM1 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 4.86e-06 | 1463 | 99 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 5.27e-06 | 199 | 99 | 8 | GO:0051147 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.36e-06 | 92 | 99 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 5.90e-06 | 8 | 99 | 3 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 8.20e-06 | 99 | 99 | 6 | GO:0045995 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 9.38e-06 | 59 | 99 | 5 | GO:0085029 | |
| GeneOntologyBiologicalProcess | neuron projection development | TRIM46 EPHA6 LAMA1 ADGRB1 CPEB3 LAMA2 LAMA5 LAMB2 LAMC3 ARHGEF25 ADAM10 CELSR3 NRXN1 SCARB2 LRP1 LRP4 AFDN NOTCH1 EPHA10 | 9.84e-06 | 1285 | 99 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 1.12e-05 | 158 | 99 | 7 | GO:0045446 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.15e-05 | 105 | 99 | 6 | GO:0048708 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 1.22e-05 | 106 | 99 | 6 | GO:0051149 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 1.26e-05 | 10 | 99 | 3 | GO:2000766 | |
| GeneOntologyBiologicalProcess | vasculature development | COL4A2 EFEMP2 LAMA1 ADGRB1 DLL1 ADAM10 LDLR CCN6 NRXN1 TIE1 JAG1 LRP1 FKBPL LTBP1 NOTCH1 NOTCH4 | 1.44e-05 | 969 | 99 | 16 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.72e-05 | 11 | 99 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.84e-05 | 114 | 99 | 6 | GO:0008593 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translational elongation | 2.28e-05 | 2 | 99 | 2 | GO:1900248 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 2.43e-05 | 321 | 99 | 9 | GO:0010001 | |
| GeneOntologyBiologicalProcess | endothelium development | 2.79e-05 | 182 | 99 | 7 | GO:0003158 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.97e-05 | 124 | 99 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | COL4A2 EFEMP2 LAMA1 ADGRB1 DLL1 LDLR CCN6 NRXN1 TIE1 JAG1 LRP1 FKBPL NOTCH1 NOTCH4 | 3.50e-05 | 817 | 99 | 14 | GO:0048514 |
| GeneOntologyBiologicalProcess | blood vessel development | COL4A2 EFEMP2 LAMA1 ADGRB1 DLL1 LDLR CCN6 NRXN1 TIE1 JAG1 LRP1 FKBPL LTBP1 NOTCH1 NOTCH4 | 3.55e-05 | 929 | 99 | 15 | GO:0001568 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.76e-05 | 14 | 99 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 3.92e-05 | 192 | 99 | 7 | GO:0045667 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 4.68e-05 | 15 | 99 | 3 | GO:0048505 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 5.34e-05 | 43 | 99 | 4 | GO:0071711 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast differentiation | 6.58e-05 | 88 | 99 | 5 | GO:0045669 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational elongation | 6.82e-05 | 3 | 99 | 2 | GO:1900247 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 6.95e-05 | 17 | 99 | 3 | GO:0040034 | |
| GeneOntologyBiologicalProcess | neuroepithelial cell differentiation | 1.05e-04 | 51 | 99 | 4 | GO:0060563 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | IFT140 PLOD3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 ITGB4 THBS3 FBN2 SCUBE2 JAG1 LRP4 AFDN NOTCH1 | 1.05e-04 | 1269 | 99 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | tube development | COL4A2 IFT140 PLOD3 EFEMP2 LAMA1 ADGRB1 LAMA5 DLL1 LDLR CCN6 SALL2 NRXN1 TIE1 JAG1 LRP1 FKBPL NOTCH1 NOTCH4 | 1.10e-04 | 1402 | 99 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | glial cell development | 1.11e-04 | 157 | 99 | 6 | GO:0021782 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.31e-04 | 54 | 99 | 4 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 1.34e-04 | 21 | 99 | 3 | GO:2000047 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.36e-04 | 4 | 99 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.36e-04 | 4 | 99 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A2 IFT140 EFEMP2 LAMA1 ADGRB1 DLL1 ADAM10 LDLR CCN6 NRXN1 TIE1 JAG1 LRP1 FKBPL LTBP1 MNAT1 NOTCH1 NOTCH4 | 1.57e-04 | 1442 | 99 | 18 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.59e-04 | 410 | 99 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.77e-04 | 23 | 99 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | nephron development | 1.94e-04 | 174 | 99 | 6 | GO:0072006 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TRIM46 COL4A2 ADGRB1 DLL1 ADAM10 CCN6 TIE1 JAG1 LRP1 LRP4 FKBPL AFDN NOTCH1 NOTCH4 ARAP1 | 2.11e-04 | 1090 | 99 | 15 | GO:0022603 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 2.20e-04 | 337 | 99 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.26e-04 | 5 | 99 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | negative regulation of translational elongation | 2.26e-04 | 5 | 99 | 2 | GO:0045900 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 2.26e-04 | 5 | 99 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.26e-04 | 5 | 99 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational elongation | 2.26e-04 | 5 | 99 | 2 | GO:0002182 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 2.26e-04 | 5 | 99 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 2.26e-04 | 5 | 99 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 2.26e-04 | 5 | 99 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | gliogenesis | 2.46e-04 | 435 | 99 | 9 | GO:0042063 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | COL4A2 EFEMP2 LAMA1 ADGRB1 LAMA5 DLL1 LDLR CCN6 NRXN1 TIE1 JAG1 LRP1 FKBPL NOTCH1 NOTCH4 | 2.96e-04 | 1125 | 99 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | epithelial cell development | 3.18e-04 | 269 | 99 | 7 | GO:0002064 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 3.22e-04 | 28 | 99 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 3.38e-04 | 6 | 99 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 3.38e-04 | 6 | 99 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 3.38e-04 | 6 | 99 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 3.38e-04 | 6 | 99 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | regulation of grooming behavior | 3.38e-04 | 6 | 99 | 2 | GO:2000821 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 3.38e-04 | 6 | 99 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 3.40e-04 | 69 | 99 | 4 | GO:0030857 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 3.82e-04 | 128 | 99 | 5 | GO:0072009 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 3.88e-04 | 198 | 99 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 4.71e-04 | 7 | 99 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 4.71e-04 | 7 | 99 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | regulation of somitogenesis | 4.71e-04 | 7 | 99 | 2 | GO:0014807 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 DLL1 ADAM10 JAG1 LRP1 AFDN NOTCH1 MEGF10 NOTCH4 | 4.84e-04 | 927 | 99 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | glomerulus development | 5.17e-04 | 77 | 99 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 5.29e-04 | 210 | 99 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | filopodium assembly | 5.43e-04 | 78 | 99 | 4 | GO:0046847 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 6.27e-04 | 8 | 99 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 6.35e-04 | 302 | 99 | 7 | GO:0001649 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 7.17e-04 | 147 | 99 | 5 | GO:0030278 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 7.40e-04 | 37 | 99 | 3 | GO:2000765 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 7.83e-04 | 313 | 99 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 8.03e-04 | 9 | 99 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 8.03e-04 | 9 | 99 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 8.65e-04 | 39 | 99 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 9.32e-04 | 40 | 99 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 9.73e-04 | 236 | 99 | 6 | GO:0061138 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.00e-03 | 10 | 99 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.00e-03 | 10 | 99 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 1.00e-03 | 10 | 99 | 2 | GO:0072310 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 PLOD3 ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 MUC5B ADAM10 ITGB4 CCN6 SNED1 THBS3 FBN2 FCGBP MEGF6 LTBP1 LTBP2 MUC5AC MUC6 FBN3 | 4.67e-14 | 656 | 100 | 23 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 PLOD3 ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 MUC5B ADAM10 ITGB4 CCN6 SNED1 THBS3 FBN2 FCGBP MEGF6 LTBP1 LTBP2 MUC5AC MUC6 FBN3 | 4.98e-14 | 658 | 100 | 23 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 PLOD3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 ADAM10 ITGB4 THBS3 FBN2 MEGF6 LTBP1 LTBP2 | 3.30e-08 | 530 | 100 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.27e-07 | 122 | 100 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 3.41e-07 | 13 | 100 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 9.24e-06 | 59 | 100 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin complex | 1.24e-05 | 10 | 100 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ADGRB1 CPEB3 ANKS1B ADAM10 CELSR3 NRXN1 CPEB4 LRP1 LRP4 AFDN NOTCH1 | 4.11e-05 | 523 | 100 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | ADGRB1 CPEB3 ANKS1B ADAM10 CELSR3 CPEB4 LRP1 LRP4 AFDN NOTCH1 | 6.06e-05 | 451 | 100 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | laminin-11 complex | 6.78e-05 | 3 | 100 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-3 complex | 6.78e-05 | 3 | 100 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.88e-05 | 17 | 100 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | asymmetric synapse | ADGRB1 CPEB3 ANKS1B ADAM10 CELSR3 CPEB4 LRP1 LRP4 AFDN NOTCH1 | 9.63e-05 | 477 | 100 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | synaptic membrane | SUSD4 ADGRB1 ADAM10 ITGB4 CELSR3 NRXN1 LRP1 CNTNAP4 LRP4 AFDN NOTCH1 | 1.08e-04 | 583 | 100 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic specialization | ADGRB1 CPEB3 ANKS1B ADAM10 CELSR3 CPEB4 LRP1 LRP4 AFDN NOTCH1 | 1.49e-04 | 503 | 100 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | neuromuscular junction | 2.03e-04 | 112 | 100 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | synaptic cleft | 5.22e-04 | 33 | 100 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHA6 ADGRB1 CPEB3 ANKS1B LAMA2 ADAM10 LDLR NRXN1 CPEB4 LRP1 CNTNAP4 LRP4 AFDN LTBP1 EPHA10 | 7.19e-04 | 1228 | 100 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic membrane | 7.30e-04 | 405 | 100 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | dendrite | EPHA6 ADGRB1 CPEB3 ANKS1B LAMA2 ADAM10 CPEB4 LRP1 CNTNAP4 LRP4 LTBP1 EPHA10 | 8.07e-04 | 858 | 100 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHA6 ADGRB1 CPEB3 ANKS1B LAMA2 ADAM10 CPEB4 LRP1 CNTNAP4 LRP4 LTBP1 EPHA10 | 8.23e-04 | 860 | 100 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | SUSD4 ADGRB1 CPEB3 ANKS1B LAMA2 ADAM10 ITGB4 CELSR3 CPEB4 LRP1 LRP4 AFDN NOTCH1 | 1.12e-03 | 1018 | 100 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | glutamatergic synapse | CPEB2 ADGRB1 CPEB3 ANKS1B LAMA5 ADAM10 ITGB4 CELSR3 NRXN1 LRP1 NOTCH1 | 1.82e-03 | 817 | 100 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | adherens junction | 3.53e-03 | 212 | 100 | 5 | GO:0005912 | |
| MousePheno | abnormal respiration | CPEB2 EFEMP2 LAMA2 MUC5B ITGB4 ITPA NELL1 CELSR3 NRXN1 TIE1 CPEB4 LRP4 DECR2 ARAP1 | 8.82e-06 | 598 | 82 | 14 | MP:0001943 |
| MousePheno | decreased circulating total protein level | 4.52e-05 | 162 | 82 | 7 | MP:0005567 | |
| MousePheno | stria vascularis degeneration | 6.76e-05 | 14 | 82 | 3 | MP:0004363 | |
| MousePheno | abnormal breathing pattern | 6.87e-05 | 303 | 82 | 9 | MP:0001951 | |
| MousePheno | abnormal somatic nervous system morphology | CPEB2 COL4A2 MPV17 CRIM1 LAMA2 LAMB2 LAMC3 DLL1 LDLR PLEKHM1 FBN2 SCARB2 JAG1 CPEB4 LRP4 NOTCH1 MEGF10 | 7.67e-05 | 1025 | 82 | 17 | MP:0002752 |
| MousePheno | abnormal pulmonary respiratory rate | 7.68e-05 | 75 | 82 | 5 | MP:0005572 | |
| MousePheno | abnormal blood vessel morphology | COL4A2 MPV17 IFT140 PLOD3 CRIM1 TRA2B EFEMP2 LAMA1 LAMA5 DLL1 ADAM10 ITGB4 LDLR THOP1 TIE1 SCARB2 JAG1 FKBPL LTBP1 NOTCH1 NOTCH4 | 8.48e-05 | 1472 | 82 | 21 | MP:0001614 |
| MousePheno | abnormal basement membrane morphology | 8.56e-05 | 40 | 82 | 4 | MP:0004272 | |
| MousePheno | abnormal ear morphology | COL4A2 MPV17 IFT140 LAMA2 LAMA5 MUC5B FBN2 NISCH SCARB2 JAG1 NOTCH1 | 8.96e-05 | 470 | 82 | 11 | MP:0002102 |
| MousePheno | aorta stenosis | 1.25e-04 | 17 | 82 | 3 | MP:0010463 | |
| MousePheno | abnormal thoracic aorta morphology | 1.34e-04 | 134 | 82 | 6 | MP:0010468 | |
| MousePheno | decreased circulating protein level | COL4A2 MPV17 KRT83 ADGRB1 LAMB2 DLL1 LRP1B LDLR FBN2 NRXN1 JAG1 LTBP1 RNF180 | 1.97e-04 | 698 | 82 | 13 | MP:0014502 |
| MousePheno | abnormal respiratory system physiology | CPEB2 EFEMP2 LAMA2 MUC5B ITGB4 ITPA NELL1 CELSR3 NRXN1 TIE1 NISCH CPEB4 LRP4 DECR2 ARAP1 | 1.98e-04 | 897 | 82 | 15 | MP:0002133 |
| MousePheno | abnormal glomerular filtration barrier function | 2.02e-04 | 4 | 82 | 2 | MP:0011856 | |
| MousePheno | abnormal hypodermis muscle layer morphology | 2.02e-04 | 4 | 82 | 2 | MP:0011157 | |
| MousePheno | abnormal somatic sensory system morphology | CPEB2 COL4A2 MPV17 CRIM1 LAMA2 LAMB2 LAMC3 DLL1 LDLR SCARB2 JAG1 NOTCH1 MEGF10 | 2.09e-04 | 702 | 82 | 13 | MP:0000959 |
| MousePheno | abnormal capillary morphology | 2.13e-04 | 93 | 82 | 5 | MP:0003658 | |
| MousePheno | abnormal cardiovascular development | COL4A2 IFT140 CRIM1 TRA2B LAMA5 DLL1 ADAM10 ITGB4 ITPA TIE1 JAG1 FKBPL LTBP1 NOTCH1 | 2.15e-04 | 802 | 82 | 14 | MP:0002925 |
| MousePheno | increased urine protein level | 2.38e-04 | 149 | 82 | 6 | MP:0002962 | |
| MousePheno | abnormal synapse morphology | 3.39e-04 | 224 | 82 | 7 | MP:0009538 | |
| MousePheno | abnormal aorta morphology | 3.48e-04 | 225 | 82 | 7 | MP:0000272 | |
| MousePheno | decreased pulmonary respiratory rate | 4.08e-04 | 25 | 82 | 3 | MP:0005574 | |
| MousePheno | abnormal phrenic nerve morphology | 4.08e-04 | 25 | 82 | 3 | MP:0001078 | |
| MousePheno | respiratory failure | 4.12e-04 | 165 | 82 | 6 | MP:0001953 | |
| MousePheno | decreased respiration | 4.83e-04 | 170 | 82 | 6 | MP:0014274 | |
| MousePheno | abnormal urine protein level | 4.83e-04 | 170 | 82 | 6 | MP:0006315 | |
| MousePheno | decreased circulating serum albumin level | 4.88e-04 | 238 | 82 | 7 | MP:0005419 | |
| MousePheno | abnormal basal lamina morphology | 5.02e-04 | 6 | 82 | 2 | MP:0004273 | |
| MousePheno | lens dislocation | 5.02e-04 | 6 | 82 | 2 | MP:0031428 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 5.02e-04 | 6 | 82 | 2 | MP:0001055 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 5.02e-04 | 6 | 82 | 2 | MP:0001054 | |
| MousePheno | albuminuria | 5.04e-04 | 63 | 82 | 4 | MP:0002871 | |
| MousePheno | abnormal respiratory function | 5.34e-04 | 399 | 82 | 9 | MP:0002327 | |
| MousePheno | abnormal aortic arch morphology | 6.65e-04 | 119 | 82 | 5 | MP:0004113 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 7.51e-04 | 70 | 82 | 4 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 7.51e-04 | 70 | 82 | 4 | MP:0005326 | |
| MousePheno | abnormal amacrine cell morphology | 7.77e-04 | 31 | 82 | 3 | MP:0005240 | |
| MousePheno | decreased circulating unsaturated transferrin level | 9.30e-04 | 8 | 82 | 2 | MP:0011897 | |
| MousePheno | absent vestibular hair cells | 9.30e-04 | 8 | 82 | 2 | MP:0004325 | |
| MousePheno | abnormal retina inner limiting membrane morphology | 9.30e-04 | 8 | 82 | 2 | MP:0010235 | |
| MousePheno | abnormal vascular branching morphogenesis | 9.35e-04 | 33 | 82 | 3 | MP:0003227 | |
| Domain | EGF-like_CS | ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 LRP1B ITGB4 LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 EPHA10 NOTCH4 | 1.03e-36 | 261 | 100 | 33 | IPR013032 |
| Domain | EGF | ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 FCGBP SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 NOTCH4 | 1.22e-36 | 235 | 100 | 32 | SM00181 |
| Domain | EGF_2 | ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 LRP1B ITGB4 LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 EPHA10 NOTCH4 | 1.73e-36 | 265 | 100 | 33 | PS01186 |
| Domain | EGF-like_dom | ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 FCGBP SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 NOTCH4 | 8.39e-36 | 249 | 100 | 32 | IPR000742 |
| Domain | EGF_1 | ZAN EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 LRP1B ITGB4 LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 NOTCH4 | 1.85e-35 | 255 | 100 | 32 | PS00022 |
| Domain | Growth_fac_rcpt_ | EPHA6 CRIM1 KRT83 EFEMP2 LAMA1 LAMA5 LAMB2 LAMC3 DLL1 LRP1B LDLR CCN6 NELL1 THBS3 FBN2 SCUBE2 MEGF6 TIE1 JAG1 LRP1 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 4.41e-32 | 156 | 100 | 26 | IPR009030 |
| Domain | EGF_3 | ZAN EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 TENM1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 MEGF10 NOTCH4 | 2.97e-27 | 235 | 100 | 26 | PS50026 |
| Domain | ASX_HYDROXYL | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 1.91e-26 | 100 | 100 | 20 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 FBN2 SCUBE2 CELSR3 MEGF6 NRXN1 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 6.75e-26 | 106 | 100 | 20 | IPR000152 |
| Domain | EGF_Ca-bd_CS | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 MEGF6 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 5.75e-25 | 97 | 100 | 19 | IPR018097 |
| Domain | EGF_CA | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 MEGF6 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 8.76e-25 | 99 | 100 | 19 | PS01187 |
| Domain | EGF_CA | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 1.37e-24 | 122 | 100 | 20 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | EFEMP2 DLL1 LRP1B LDLR SNED1 NELL1 THBS3 FBN2 SCUBE2 CELSR3 MEGF6 JAG1 LRP1 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 1.94e-24 | 124 | 100 | 20 | IPR001881 |
| Domain | EGF | ZAN DLL1 LRP1B SNED1 SCUBE2 CELSR3 MEGF6 NRXN1 TIE1 JAG1 LRP1 CNTNAP4 DLK2 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 1.16e-22 | 126 | 100 | 19 | PF00008 |
| Domain | EGF_CA | EFEMP2 LRP1B LDLR NELL1 THBS3 FBN2 SCUBE2 MEGF6 JAG1 LRP1 LRP4 LTBP1 LTBP2 FBN3 NOTCH1 NOTCH4 | 9.28e-21 | 86 | 100 | 16 | PF07645 |
| Domain | hEGF | 1.48e-16 | 28 | 100 | 10 | PF12661 | |
| Domain | EGF_extracell | LRP1B ITGB4 NELL1 MEGF6 TIE1 JAG1 TENM1 DLK2 LTBP2 NOTCH1 MEGF10 | 1.63e-14 | 60 | 100 | 11 | IPR013111 |
| Domain | EGF_2 | LRP1B ITGB4 NELL1 MEGF6 TIE1 JAG1 TENM1 DLK2 LTBP2 NOTCH1 MEGF10 | 1.63e-14 | 60 | 100 | 11 | PF07974 |
| Domain | VWC_out | 3.65e-14 | 19 | 100 | 8 | SM00215 | |
| Domain | cEGF | 7.33e-13 | 26 | 100 | 8 | IPR026823 | |
| Domain | cEGF | 7.33e-13 | 26 | 100 | 8 | PF12662 | |
| Domain | Laminin_EGF | 1.06e-11 | 35 | 100 | 8 | PF00053 | |
| Domain | EGF_Lam | 1.06e-11 | 35 | 100 | 8 | SM00180 | |
| Domain | Laminin_EGF | 2.18e-11 | 38 | 100 | 8 | IPR002049 | |
| Domain | VWF_dom | 5.16e-11 | 42 | 100 | 8 | IPR001007 | |
| Domain | Laminin_G | 7.81e-10 | 58 | 100 | 8 | IPR001791 | |
| Domain | VWC | 1.12e-09 | 38 | 100 | 7 | SM00214 | |
| Domain | LDLR_class-A_CS | 1.64e-09 | 40 | 100 | 7 | IPR023415 | |
| Domain | Laminin_G_2 | 1.64e-09 | 40 | 100 | 7 | PF02210 | |
| Domain | TIL | 3.06e-09 | 12 | 100 | 5 | PF01826 | |
| Domain | C8 | 3.06e-09 | 12 | 100 | 5 | PF08742 | |
| Domain | LamG | 3.32e-09 | 44 | 100 | 7 | SM00282 | |
| Domain | Ldl_recept_a | 3.92e-09 | 45 | 100 | 7 | PF00057 | |
| Domain | - | 4.60e-09 | 46 | 100 | 7 | 4.10.400.10 | |
| Domain | Unchr_dom_Cys-rich | 4.95e-09 | 13 | 100 | 5 | IPR014853 | |
| Domain | C8 | 4.95e-09 | 13 | 100 | 5 | SM00832 | |
| Domain | LDLRA_1 | 6.27e-09 | 48 | 100 | 7 | PS01209 | |
| Domain | LDLRA_2 | 7.29e-09 | 49 | 100 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.29e-09 | 49 | 100 | 7 | IPR002172 | |
| Domain | LDLa | 7.29e-09 | 49 | 100 | 7 | SM00192 | |
| Domain | TIL_dom | 7.66e-09 | 14 | 100 | 5 | IPR002919 | |
| Domain | EGF_LAM_2 | 1.08e-08 | 30 | 100 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 1.08e-08 | 30 | 100 | 6 | PS01248 | |
| Domain | VWD | 1.66e-08 | 16 | 100 | 5 | SM00216 | |
| Domain | VWF_type-D | 1.66e-08 | 16 | 100 | 5 | IPR001846 | |
| Domain | Laminin_N | 1.66e-08 | 16 | 100 | 5 | IPR008211 | |
| Domain | LAMININ_NTER | 1.66e-08 | 16 | 100 | 5 | PS51117 | |
| Domain | VWFD | 1.66e-08 | 16 | 100 | 5 | PS51233 | |
| Domain | Laminin_N | 1.66e-08 | 16 | 100 | 5 | PF00055 | |
| Domain | VWD | 1.66e-08 | 16 | 100 | 5 | PF00094 | |
| Domain | LamNT | 1.66e-08 | 16 | 100 | 5 | SM00136 | |
| Domain | ConA-like_dom | TRIM46 ZAN LAMA1 LAMA2 LAMA5 ITGB4 NELL1 THBS3 CELSR3 NRXN1 CNTNAP4 | 2.55e-08 | 219 | 100 | 11 | IPR013320 |
| Domain | TB | 2.67e-08 | 7 | 100 | 4 | PF00683 | |
| Domain | Galactose-bd-like | 3.87e-08 | 94 | 100 | 8 | IPR008979 | |
| Domain | - | 4.21e-08 | 95 | 100 | 8 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 4.87e-08 | 38 | 100 | 6 | PS50025 | |
| Domain | LAMININ_IVA | 5.33e-08 | 8 | 100 | 4 | PS51115 | |
| Domain | Laminin_B | 5.33e-08 | 8 | 100 | 4 | PF00052 | |
| Domain | - | 5.33e-08 | 8 | 100 | 4 | 3.90.290.10 | |
| Domain | LamB | 5.33e-08 | 8 | 100 | 4 | SM00281 | |
| Domain | Laminin_IV | 5.33e-08 | 8 | 100 | 4 | IPR000034 | |
| Domain | TB | 9.55e-08 | 9 | 100 | 4 | PS51364 | |
| Domain | TB_dom | 9.55e-08 | 9 | 100 | 4 | IPR017878 | |
| Domain | CEBP_ZZ | 5.93e-07 | 4 | 100 | 3 | IPR032296 | |
| Domain | CEBP_ZZ | 5.93e-07 | 4 | 100 | 3 | PF16366 | |
| Domain | RRM_7 | 5.93e-07 | 4 | 100 | 3 | PF16367 | |
| Domain | Ldl_recept_b | 7.43e-07 | 14 | 100 | 4 | PF00058 | |
| Domain | LDLRB | 7.43e-07 | 14 | 100 | 4 | PS51120 | |
| Domain | LY | 1.01e-06 | 15 | 100 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.01e-06 | 15 | 100 | 4 | IPR000033 | |
| Domain | VWFC_1 | 1.31e-06 | 36 | 100 | 5 | PS01208 | |
| Domain | Laminin_aI | 1.48e-06 | 5 | 100 | 3 | IPR009254 | |
| Domain | Laminin_I | 1.48e-06 | 5 | 100 | 3 | PF06008 | |
| Domain | Laminin_II | 1.48e-06 | 5 | 100 | 3 | PF06009 | |
| Domain | Laminin_domII | 1.48e-06 | 5 | 100 | 3 | IPR010307 | |
| Domain | VWFC_2 | 1.74e-06 | 38 | 100 | 5 | PS50184 | |
| Domain | - | 1.98e-06 | 39 | 100 | 5 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.58e-06 | 46 | 100 | 5 | IPR011042 | |
| Domain | CT | 5.26e-06 | 22 | 100 | 4 | SM00041 | |
| Domain | Cys_knot_C | 8.98e-06 | 25 | 100 | 4 | IPR006207 | |
| Domain | CTCK_2 | 8.98e-06 | 25 | 100 | 4 | PS01225 | |
| Domain | VWC | 1.44e-05 | 28 | 100 | 4 | PF00093 | |
| Domain | DUF5050 | 2.84e-05 | 2 | 100 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.84e-05 | 2 | 100 | 2 | PF16472 | |
| Domain | - | 4.48e-05 | 73 | 100 | 5 | 2.60.120.260 | |
| Domain | Glyco_hormone_CN | 6.47e-05 | 15 | 100 | 3 | IPR006208 | |
| Domain | Cys_knot | 6.47e-05 | 15 | 100 | 3 | PF00007 | |
| Domain | TILa | 8.48e-05 | 3 | 100 | 2 | PF12714 | |
| Domain | TILa_dom | 8.48e-05 | 3 | 100 | 2 | IPR025615 | |
| Domain | FBN | 8.48e-05 | 3 | 100 | 2 | IPR011398 | |
| Domain | CTCK_1 | 1.15e-04 | 18 | 100 | 3 | PS01185 | |
| Domain | Notch | 1.69e-04 | 4 | 100 | 2 | IPR008297 | |
| Domain | NODP | 1.69e-04 | 4 | 100 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.69e-04 | 4 | 100 | 2 | IPR011656 | |
| Domain | DSL | 1.69e-04 | 4 | 100 | 2 | PF01414 | |
| Domain | Notch_NOD_dom | 1.69e-04 | 4 | 100 | 2 | IPR010660 | |
| Domain | NOD | 1.69e-04 | 4 | 100 | 2 | PF06816 | |
| Domain | DSL | 1.69e-04 | 4 | 100 | 2 | SM00051 | |
| Domain | NOD | 1.69e-04 | 4 | 100 | 2 | SM01338 | |
| Domain | NODP | 1.69e-04 | 4 | 100 | 2 | SM01339 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 PLOD3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 ADAM10 ITGB4 FBN2 NRXN1 LRP4 LTBP1 LTBP2 FBN3 | 6.23e-12 | 300 | 78 | 16 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.22e-10 | 30 | 78 | 7 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.07e-09 | 59 | 78 | 8 | M27218 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.05e-09 | 11 | 78 | 5 | M158 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 6.37e-09 | 27 | 78 | 6 | M39545 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.89e-08 | 84 | 78 | 8 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 3.00e-08 | 7 | 78 | 4 | M27199 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.85e-07 | 46 | 78 | 6 | M239 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.82e-07 | 30 | 78 | 5 | M27772 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.97e-07 | 13 | 78 | 4 | M47423 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 9.58e-07 | 33 | 78 | 5 | M39503 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.13e-06 | 15 | 78 | 4 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.50e-06 | 16 | 78 | 4 | M47424 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.73e-06 | 37 | 78 | 5 | M27134 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.26e-06 | 39 | 78 | 5 | MM14604 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.76e-06 | 72 | 78 | 6 | M39403 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.92e-06 | 41 | 78 | 5 | M27778 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.99e-06 | 73 | 78 | 6 | MM15906 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.79e-06 | 76 | 78 | 6 | M27219 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.18e-06 | 44 | 78 | 5 | M26969 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 6.81e-06 | 84 | 78 | 6 | M3228 | |
| Pathway | WP_FOCAL_ADHESION | 8.76e-06 | 187 | 78 | 8 | MM15913 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.00e-05 | 25 | 78 | 4 | M39713 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.21e-05 | 258 | 78 | 9 | MM14572 | |
| Pathway | WP_FOCAL_ADHESION | 1.38e-05 | 199 | 78 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.38e-05 | 199 | 78 | 8 | M7253 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.47e-05 | 96 | 78 | 6 | M39834 | |
| Pathway | PID_NOTCH_PATHWAY | 1.81e-05 | 59 | 78 | 5 | M17 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 2.44e-05 | 31 | 78 | 4 | M592 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.60e-05 | 11 | 78 | 3 | M27882 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.77e-05 | 32 | 78 | 4 | MM14854 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.13e-05 | 66 | 78 | 5 | MM15925 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.46e-05 | 12 | 78 | 3 | M47532 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.62e-05 | 68 | 78 | 5 | M27303 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.16e-05 | 39 | 78 | 4 | MM14601 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.07e-05 | 15 | 78 | 3 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.46e-05 | 79 | 78 | 5 | M27643 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 8.66e-05 | 16 | 78 | 3 | M27410 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.91e-05 | 82 | 78 | 5 | MM15922 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.05e-04 | 17 | 78 | 3 | M27412 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.05e-04 | 17 | 78 | 3 | M39389 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.09e-04 | 45 | 78 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.19e-04 | 46 | 78 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.29e-04 | 47 | 78 | 4 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.48e-04 | 19 | 78 | 3 | MM15594 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.52e-04 | 49 | 78 | 4 | M618 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.02e-04 | 21 | 78 | 3 | MM15706 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.33e-04 | 22 | 78 | 3 | M27210 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.58e-04 | 302 | 78 | 8 | M39719 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.66e-04 | 23 | 78 | 3 | M556 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.93e-04 | 58 | 78 | 4 | M29616 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.99e-04 | 5 | 78 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.99e-04 | 5 | 78 | 2 | MM14733 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.43e-04 | 25 | 78 | 3 | M27879 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.56e-04 | 61 | 78 | 4 | M39540 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.87e-04 | 26 | 78 | 3 | M27483 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.31e-04 | 326 | 78 | 8 | MM15917 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 4.47e-04 | 6 | 78 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 4.47e-04 | 6 | 78 | 2 | M22074 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.47e-04 | 6 | 78 | 2 | M27068 | |
| Pathway | WP_CANCER_PATHWAYS | COL4A2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 DLL1 JAG1 NOTCH1 NOTCH4 | 4.64e-04 | 507 | 78 | 10 | M48302 |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.82e-04 | 66 | 78 | 4 | M18 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.58e-04 | 339 | 78 | 8 | M39736 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.94e-04 | 30 | 78 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 5.94e-04 | 30 | 78 | 3 | MM15812 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 6.23e-04 | 7 | 78 | 2 | MM14734 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 7.44e-04 | 74 | 78 | 4 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 7.89e-04 | 33 | 78 | 3 | M604 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 1.06e-03 | 9 | 78 | 2 | M39869 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.06e-03 | 9 | 78 | 2 | MM15117 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.06e-03 | 9 | 78 | 2 | M47866 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.06e-03 | 140 | 78 | 5 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.09e-03 | 82 | 78 | 4 | M594 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.11e-03 | 37 | 78 | 3 | M39506 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.17e-03 | 143 | 78 | 5 | M27275 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 1.32e-03 | 10 | 78 | 2 | MM15839 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 1.61e-03 | 11 | 78 | 2 | M39647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.61e-03 | 11 | 78 | 2 | M47865 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.92e-03 | 12 | 78 | 2 | M47533 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.96e-03 | 45 | 78 | 3 | M39864 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.97e-03 | 161 | 78 | 5 | M39770 | |
| Pathway | PID_PS1_PATHWAY | 2.08e-03 | 46 | 78 | 3 | M70 | |
| Pathway | REACTOME_NEPHRON_DEVELOPMENT | 2.27e-03 | 13 | 78 | 2 | M48245 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.27e-03 | 13 | 78 | 2 | M47534 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 2.27e-03 | 13 | 78 | 2 | M42551 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 2.63e-03 | 14 | 78 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 2.63e-03 | 14 | 78 | 2 | M16173 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.63e-03 | 14 | 78 | 2 | M27808 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.80e-03 | 51 | 78 | 3 | M27311 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 3.03e-03 | 15 | 78 | 2 | M42552 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 3.85e-03 | 57 | 78 | 3 | M48326 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 3.90e-03 | 17 | 78 | 2 | M39443 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.13e-03 | 118 | 78 | 4 | M39852 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.37e-03 | 18 | 78 | 2 | MM15023 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.37e-03 | 18 | 78 | 2 | M614 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 4.37e-03 | 18 | 78 | 2 | M42559 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.45e-03 | 60 | 78 | 3 | MM15636 | |
| Pathway | WP_STATIN_PATHWAY | 4.86e-03 | 19 | 78 | 2 | MM15868 | |
| Pubmed | COL4A2 PLOD3 LAMA1 LAMA2 LAMA5 LAMB2 ADAM10 FBN2 MEGF6 LTBP1 LTBP2 | 4.09e-12 | 175 | 101 | 11 | 28071719 | |
| Pubmed | COL4A2 PLOD3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 ADAM10 LTBP1 LTBP2 | 6.55e-11 | 167 | 101 | 10 | 22159717 | |
| Pubmed | 7.03e-11 | 118 | 101 | 9 | 21078624 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.51e-11 | 11 | 101 | 5 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 8.51e-11 | 11 | 101 | 5 | 21524702 | |
| Pubmed | 1.13e-10 | 26 | 101 | 6 | 24742657 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A2 PLOD3 CRIM1 LAMA1 LAMA5 LAMB2 LAMC3 ADAM10 LRP1B ITGB4 LDLR THBS3 FBN2 CELSR3 SCARB2 LRP1 LRP4 LTBP1 LTBP2 NOTCH1 | 2.33e-10 | 1201 | 101 | 20 | 35696571 |
| Pubmed | 2.36e-10 | 13 | 101 | 5 | 36350252 | ||
| Pubmed | 3.34e-10 | 5 | 101 | 4 | 20554499 | ||
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 3.34e-10 | 5 | 101 | 4 | 16581764 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 5.48e-10 | 15 | 101 | 5 | 15895400 | |
| Pubmed | 7.96e-10 | 16 | 101 | 5 | 17601529 | ||
| Pubmed | 1.55e-09 | 18 | 101 | 5 | 11311202 | ||
| Pubmed | 1.83e-09 | 40 | 101 | 6 | 27068110 | ||
| Pubmed | 2.14e-09 | 41 | 101 | 6 | 22675208 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.33e-09 | 7 | 101 | 4 | 12846471 | |
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 14557481 | ||
| Pubmed | 2.80e-09 | 20 | 101 | 5 | 22911573 | ||
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 9858718 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 11118901 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 16245338 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 8.35e-09 | 9 | 101 | 4 | 10837027 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.17e-08 | 26 | 101 | 5 | 34189436 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.39e-08 | 10 | 101 | 4 | 23665443 | |
| Pubmed | 1.39e-08 | 10 | 101 | 4 | 11784026 | ||
| Pubmed | 1.39e-08 | 10 | 101 | 4 | 9034910 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.43e-08 | 27 | 101 | 5 | 21791528 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 2.10e-08 | 29 | 101 | 5 | 21402740 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 2.18e-08 | 11 | 101 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.18e-08 | 11 | 101 | 4 | 15499562 | |
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 10878608 | ||
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 12866128 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 2.38e-08 | 3 | 101 | 3 | 20812035 | |
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 2.38e-08 | 3 | 101 | 3 | 28863329 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 22080880 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 14988227 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15781650 | ||
| Pubmed | CPEB2, a novel putative translational regulator in mouse haploid germ cells. | 2.38e-08 | 3 | 101 | 3 | 12672660 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 26341090 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15939383 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 9049978 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 26794322 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 15465494 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 11381080 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 9396756 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.69e-08 | 13 | 101 | 4 | 11578869 | |
| Pubmed | Notch signaling is required for the maintenance of enteric neural crest progenitors. | 4.69e-08 | 13 | 101 | 4 | 18832397 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.87e-08 | 248 | 101 | 9 | 24006456 | |
| Pubmed | 6.34e-08 | 71 | 101 | 6 | 33541421 | ||
| Pubmed | 6.56e-08 | 14 | 101 | 4 | 14757642 | ||
| Pubmed | 8.92e-08 | 15 | 101 | 4 | 12971992 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 8.92e-08 | 15 | 101 | 4 | 12921739 | |
| Pubmed | 8.92e-08 | 15 | 101 | 4 | 10625553 | ||
| Pubmed | 8.92e-08 | 15 | 101 | 4 | 9264260 | ||
| Pubmed | CPEB2-dependent translation of long 3'-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue. | 9.49e-08 | 4 | 101 | 3 | 30177570 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 12871996 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 9.49e-08 | 4 | 101 | 3 | 22390640 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 17984306 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 36376768 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 2099832 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 23807779 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 9858728 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 27354212 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 9315665 | ||
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 9.49e-08 | 4 | 101 | 3 | 23300864 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 17471237 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 9.49e-08 | 4 | 101 | 3 | 29869461 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 12676567 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.19e-07 | 16 | 101 | 4 | 12617809 | |
| Pubmed | 1.19e-07 | 16 | 101 | 4 | 17273555 | ||
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 1.19e-07 | 16 | 101 | 4 | 17229764 | |
| Pubmed | 1.19e-07 | 16 | 101 | 4 | 10842072 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.21e-07 | 79 | 101 | 6 | 18757743 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLOD3 FNTB LAMA5 LAMB2 LAMC3 DLL1 ITGB4 LDLR PLEKHM1 CELSR3 MEGF6 NISCH LRP3 LRP4 NOTCH1 ARAP1 | 1.23e-07 | 1105 | 101 | 16 | 35748872 |
| Pubmed | 1.55e-07 | 17 | 101 | 4 | 18694942 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.55e-07 | 17 | 101 | 4 | 15056720 | |
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.55e-07 | 17 | 101 | 4 | 15821257 | |
| Pubmed | 1.99e-07 | 18 | 101 | 4 | 18093989 | ||
| Pubmed | 1.99e-07 | 18 | 101 | 4 | 15689374 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.01e-07 | 86 | 101 | 6 | 28327460 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 20383322 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 11969289 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12354787 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 2.37e-07 | 5 | 101 | 3 | 9415429 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 11713346 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12175503 | ||
| Pubmed | Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). | 2.37e-07 | 5 | 101 | 3 | 11964076 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 19047013 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 19682396 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 2.37e-07 | 5 | 101 | 3 | 9389447 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 2.37e-07 | 5 | 101 | 3 | 11006133 | |
| Pubmed | A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons. | 2.37e-07 | 5 | 101 | 3 | 20639532 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 10964500 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12743034 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 21602525 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 11829758 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 15882997 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 27118257 | ||
| Interaction | NTN5 interactions | 1.51e-09 | 24 | 99 | 6 | int:NTN5 | |
| Interaction | IGFL3 interactions | 3.27e-09 | 75 | 99 | 8 | int:IGFL3 | |
| Interaction | CACNA1A interactions | 1.65e-07 | 123 | 99 | 8 | int:CACNA1A | |
| Interaction | MFAP5 interactions | 2.04e-07 | 52 | 99 | 6 | int:MFAP5 | |
| Interaction | ZFP41 interactions | 3.57e-07 | 57 | 99 | 6 | int:ZFP41 | |
| Interaction | FBXO2 interactions | PLOD3 LAMA1 LAMA5 LAMB2 LAMC3 ADAM10 LRP1B SNED1 FBN2 CELSR3 JAG1 NOTCH1 | 8.24e-07 | 411 | 99 | 12 | int:FBXO2 |
| Interaction | CCN6 interactions | 2.01e-06 | 19 | 99 | 4 | int:CCN6 | |
| Interaction | FOXD4L6 interactions | 4.15e-06 | 49 | 99 | 5 | int:FOXD4L6 | |
| Interaction | ZNF408 interactions | 7.40e-06 | 145 | 99 | 7 | int:ZNF408 | |
| Interaction | HOXA1 interactions | ARMC7 KRT83 EFEMP2 LAMA5 LAMB2 ITGB4 NELL1 MEGF6 LTBP1 NOTCH1 | 1.01e-05 | 356 | 99 | 10 | int:HOXA1 |
| Interaction | NOTCH3 interactions | 1.99e-05 | 113 | 99 | 6 | int:NOTCH3 | |
| Interaction | ZDHHC15 interactions | 3.53e-05 | 125 | 99 | 6 | int:ZDHHC15 | |
| Interaction | MBD1 interactions | 3.86e-05 | 77 | 99 | 5 | int:MBD1 | |
| Interaction | CRP interactions | 3.86e-05 | 77 | 99 | 5 | int:CRP | |
| Interaction | IGSF5 interactions | 4.02e-05 | 14 | 99 | 3 | int:IGSF5 | |
| Interaction | ZNF747 interactions | 4.37e-05 | 40 | 99 | 4 | int:ZNF747 | |
| Interaction | DEFB123 interactions | 6.15e-05 | 16 | 99 | 3 | int:DEFB123 | |
| Interaction | ZNF260 interactions | 6.15e-05 | 16 | 99 | 3 | int:ZNF260 | |
| Interaction | SIRPD interactions | 6.57e-05 | 86 | 99 | 5 | int:SIRPD | |
| Interaction | NEURL1 interactions | 7.44e-05 | 17 | 99 | 3 | int:NEURL1 | |
| Interaction | FBN1 interactions | 1.15e-04 | 51 | 99 | 4 | int:FBN1 | |
| Interaction | C9orf163 interactions | 1.15e-04 | 51 | 99 | 4 | int:C9orf163 | |
| Interaction | ZNF224 interactions | 1.23e-04 | 20 | 99 | 3 | int:ZNF224 | |
| Interaction | ZNF444 interactions | 1.77e-04 | 106 | 99 | 5 | int:ZNF444 | |
| Interaction | ATXN7 interactions | 2.02e-04 | 109 | 99 | 5 | int:ATXN7 | |
| Interaction | MANEA interactions | 2.16e-04 | 60 | 99 | 4 | int:MANEA | |
| Interaction | NOTCH2 interactions | 2.37e-04 | 423 | 99 | 9 | int:NOTCH2 | |
| Cytoband | 11p15.5 | 1.40e-04 | 118 | 101 | 4 | 11p15.5 | |
| GeneFamily | Laminin subunits | 5.83e-10 | 12 | 70 | 5 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 9.45e-10 | 13 | 70 | 5 | 634 | |
| GeneFamily | CD molecules|Mucins | 7.03e-05 | 21 | 70 | 3 | 648 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 8.82e-05 | 4 | 70 | 2 | 628 | |
| GeneFamily | Sterile alpha motif domain containing | 3.76e-04 | 88 | 70 | 4 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 3.88e-04 | 160 | 70 | 5 | 555 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.30e-03 | 14 | 70 | 2 | 1095 | |
| GeneFamily | Ankyrin repeat domain containing | 2.46e-03 | 242 | 70 | 5 | 403 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.87e-03 | 27 | 70 | 2 | 1253 | |
| GeneFamily | RNA binding motif containing | 9.37e-03 | 213 | 70 | 4 | 725 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 CCN6 SNED1 NELL1 THBS3 FBN2 LTBP1 LTBP2 FBN3 | 1.26e-15 | 196 | 101 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 CCN6 SNED1 NELL1 THBS3 FBN2 LTBP1 LTBP2 FBN3 | 1.00e-14 | 275 | 101 | 16 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 CCN6 SNED1 NELL1 THBS3 FBN2 LTBP1 LTBP2 | 2.17e-14 | 191 | 101 | 14 | MM17059 |
| Coexpression | NABA_MATRISOME | COL4A2 PLOD3 CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 MUC5B ADAM10 CCN6 SNED1 NELL1 THBS3 FBN2 SCUBE2 IL1F10 MEGF6 LTBP1 LTBP2 MUC5AC MUC6 FBN3 MEGF10 | 9.27e-14 | 1026 | 101 | 25 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 CCN6 SNED1 NELL1 THBS3 FBN2 LTBP1 LTBP2 | 1.43e-13 | 270 | 101 | 15 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A2 PLOD3 CRIM1 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB2 LAMC3 MUC5B ADAM10 CCN6 SNED1 NELL1 THBS3 FBN2 SCUBE2 IL1F10 MEGF6 LTBP1 LTBP2 MUC5AC MUC6 MEGF10 | 5.21e-13 | 1008 | 101 | 24 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 9.72e-09 | 40 | 101 | 6 | M5887 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TRIM46 CPEB2 CRIM1 ADGRB1 CPEB3 ANKS1B LAMA5 LRP1B NELL1 CELSR3 MEGF6 NRXN1 SLC16A14 CPEB4 TSPAN7 TENM1 CNTNAP4 SARDH | 2.12e-07 | 1106 | 101 | 18 | M39071 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.65e-07 | 16 | 101 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.65e-07 | 16 | 101 | 4 | M2207 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A2 EFEMP2 LAMA5 LAMB2 LAMC3 SNED1 SCUBE2 CLIC2 SCN7A LRP1 LTBP2 NOTCH4 | 5.79e-07 | 505 | 101 | 12 | M39167 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.74e-06 | 23 | 101 | 4 | M48001 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A2 MRGPRF LAMA1 DLL1 ARHGEF25 ITGB4 TIE1 JAG1 LRP1 DLK2 LRP4 | 2.45e-06 | 479 | 101 | 11 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A2 MRGPRF LAMA1 DLL1 ARHGEF25 ITGB4 TIE1 JAG1 LRP1 DLK2 LRP4 | 2.66e-06 | 483 | 101 | 11 | MM1082 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.33e-06 | 163 | 101 | 7 | M12112 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A2 CRIM1 MRGPRF EFEMP2 LAMB2 ARHGEF25 LDLR CCN6 NRXN1 JAG1 LTBP2 RNF180 MEGF10 | 7.96e-06 | 767 | 101 | 13 | M39209 |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | TRIM46 MPV17 SUSD4 LAMB2 THBS3 NRXN1 CPEB4 LRP1 DECR2 MEGF10 | 9.43e-06 | 449 | 101 | 10 | M2013 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.21e-05 | 365 | 101 | 9 | M39018 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.27e-05 | 200 | 101 | 7 | M5930 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN | 1.27e-05 | 200 | 101 | 7 | M7508 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.42e-05 | 135 | 101 | 6 | M5825 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | TRIM46 CPEB2 ADGRB1 CPEB3 LRP1B NELL1 MEGF6 NRXN1 CPEB4 SCN7A TSPAN7 TENM1 | 1.70e-05 | 703 | 101 | 12 | M39070 |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 2.08e-05 | 42 | 101 | 4 | M5895 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | TRIM46 MPV17 SUSD4 LAMB2 THBS3 NRXN1 CPEB4 LRP1 DECR2 MEGF10 | 2.26e-05 | 497 | 101 | 10 | MM863 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.63e-05 | 17 | 101 | 3 | M47995 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 3.81e-05 | 325 | 101 | 8 | M39053 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 5.21e-05 | 440 | 101 | 9 | M39039 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 6.19e-05 | 450 | 101 | 9 | M39072 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 6.91e-05 | 179 | 101 | 6 | M39308 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 7.08e-05 | 355 | 101 | 8 | M45758 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 7.95e-05 | 465 | 101 | 9 | M39066 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 8.03e-05 | 59 | 101 | 4 | M47989 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | 8.75e-05 | 366 | 101 | 8 | M39052 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | COL4A2 CRIM1 FNTB LAMA2 SIRT3 CELSR3 TIE1 LRP4 LTBP1 LTBP2 SARDH | 1.06e-04 | 721 | 101 | 11 | M1999 |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.15e-04 | 283 | 101 | 7 | M39117 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 1.20e-04 | 124 | 101 | 5 | M45686 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP | 1.24e-04 | 199 | 101 | 6 | M8294 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A2 CRIM1 MRGPRF EFEMP2 LAMB2 FCGBP SCUBE2 SLC16A14 LTBP1 | 1.24e-04 | 493 | 101 | 9 | M19391 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.24e-04 | 385 | 101 | 8 | M39264 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CRIM1 KRT83 LAMA2 LAMA5 ARHGEF25 FBN2 FKBPL LTBP1 LTBP2 NOTCH1 | 1.25e-04 | 610 | 101 | 10 | M3854 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.52e-04 | 27 | 101 | 3 | M47994 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN | 1.79e-04 | 135 | 101 | 5 | M6759 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 1.89e-04 | 29 | 101 | 3 | M47987 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CRIM1 KRT83 LAMA2 LAMA5 ARHGEF25 FBN2 FKBPL LTBP1 LTBP2 NOTCH1 | 2.08e-04 | 650 | 101 | 10 | MM1042 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.18e-04 | 6 | 101 | 2 | M48000 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.54e-04 | 32 | 101 | 3 | M5903 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 2.64e-04 | 546 | 101 | 9 | M3837 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 3.32e-04 | 35 | 101 | 3 | M16637 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.32e-04 | 35 | 101 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.61e-04 | 36 | 101 | 3 | MM1212 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.05e-04 | 8 | 101 | 2 | M9884 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 7.76e-07 | 281 | 99 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 7.76e-07 | 281 | 99 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | COL4A2 CRIM1 EFEMP2 LAMA2 LAMA5 LAMB2 ARHGEF25 JAG1 SCN7A TSPAN7 LRP1 | 8.61e-06 | 453 | 99 | 11 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | COL4A2 CRIM1 LAMA5 LAMB2 DLL1 TIE1 JAG1 TSPAN7 AFDN LTBP2 NOTCH4 | 9.16e-06 | 456 | 99 | 11 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | COL4A2 CRIM1 LAMA5 LAMB2 DLL1 TIE1 JAG1 TSPAN7 AFDN LTBP2 NOTCH4 | 9.74e-06 | 459 | 99 | 11 | GSM777037_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.80e-05 | 175 | 99 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL4A2 EFEMP2 LAMA2 LAMA5 LAMB2 ARHGEF25 SCN7A TSPAN7 LRP1 LTBP1 | 6.41e-05 | 466 | 99 | 10 | GSM777050_500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 9.02e-05 | 19 | 99 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.24e-04 | 165 | 99 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500 | 1.33e-04 | 105 | 99 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.02e-04 | 62 | 99 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.42e-04 | 65 | 99 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.77e-04 | 455 | 99 | 9 | GSM777055_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-10 | 184 | 101 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-10 | 184 | 101 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-10 | 184 | 101 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-09 | 175 | 101 | 8 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-09 | 175 | 101 | 8 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 9.40e-09 | 183 | 101 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.40e-09 | 183 | 101 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-08 | 188 | 101 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.16e-08 | 188 | 101 | 8 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-08 | 190 | 101 | 8 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-08 | 190 | 101 | 8 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-08 | 190 | 101 | 8 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-08 | 191 | 101 | 8 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-08 | 192 | 101 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 193 | 101 | 8 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 193 | 101 | 8 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-08 | 193 | 101 | 8 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 193 | 101 | 8 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-08 | 196 | 101 | 8 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-08 | 199 | 101 | 8 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 200 | 101 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 200 | 101 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 200 | 101 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.88e-08 | 200 | 101 | 8 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-07 | 166 | 101 | 7 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-07 | 166 | 101 | 7 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-07 | 166 | 101 | 7 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-07 | 176 | 101 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-07 | 176 | 101 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-07 | 180 | 101 | 7 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-07 | 180 | 101 | 7 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-07 | 180 | 101 | 7 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.97e-07 | 182 | 101 | 7 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-07 | 182 | 101 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 2.12e-07 | 184 | 101 | 7 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 185 | 101 | 7 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 185 | 101 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 185 | 101 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-07 | 189 | 101 | 7 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-07 | 189 | 101 | 7 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-07 | 191 | 101 | 7 | 0e8a73f01e3ec95d242c09231bcf3790324d0a67 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-07 | 191 | 101 | 7 | 54bbccc554f43ba2ebdf9ea191b94c8f16081b53 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.73e-07 | 191 | 101 | 7 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | EC|World / Lineage and Cell class | 2.83e-07 | 192 | 101 | 7 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.83e-07 | 192 | 101 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-07 | 192 | 101 | 7 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 193 | 101 | 7 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.93e-07 | 193 | 101 | 7 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 193 | 101 | 7 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-07 | 193 | 101 | 7 | 1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 193 | 101 | 7 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | PND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-07 | 193 | 101 | 7 | f3c743b340fc588bc8effd375b12e2c7cbfa49d2 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-07 | 194 | 101 | 7 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.14e-07 | 195 | 101 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.14e-07 | 195 | 101 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-07 | 195 | 101 | 7 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 196 | 101 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 196 | 101 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-07 | 197 | 101 | 7 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-07 | 197 | 101 | 7 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.37e-07 | 197 | 101 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.37e-07 | 197 | 101 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-07 | 198 | 101 | 7 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-07 | 199 | 101 | 7 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-07 | 199 | 101 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.61e-07 | 199 | 101 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-07 | 199 | 101 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.61e-07 | 199 | 101 | 7 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.61e-07 | 199 | 101 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-07 | 199 | 101 | 7 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.73e-07 | 200 | 101 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-07 | 200 | 101 | 7 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.73e-07 | 200 | 101 | 7 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.73e-07 | 200 | 101 | 7 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-07 | 200 | 101 | 7 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.73e-07 | 200 | 101 | 7 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-07 | 200 | 101 | 7 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.73e-07 | 200 | 101 | 7 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-07 | 200 | 101 | 7 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-06 | 148 | 101 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 156 | 101 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 156 | 101 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 157 | 101 | 6 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-06 | 162 | 101 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-06 | 166 | 101 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.68e-06 | 172 | 101 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-06 | 173 | 101 | 6 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-06 | 173 | 101 | 6 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| Computational | Metal / Ca ion binding. | 2.16e-05 | 133 | 69 | 7 | MODULE_324 | |
| Drug | AC1L1G72 | 7.03e-10 | 11 | 101 | 5 | CID000003553 | |
| Drug | monatepil | 2.87e-09 | 29 | 101 | 6 | CID000060810 | |
| Drug | kalinin | 1.59e-07 | 55 | 101 | 6 | CID000032518 | |
| Drug | AC1L1B58 | 1.70e-07 | 29 | 101 | 5 | CID000001288 | |
| Drug | Calcort | 6.95e-07 | 38 | 101 | 5 | CID000026709 | |
| Drug | 1,2-dimethylhydrazine | 2.31e-06 | 86 | 101 | 6 | CID000001322 | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.24e-06 | 152 | 101 | 7 | 6823_UP | |
| Drug | CC270 | 6.44e-06 | 59 | 101 | 5 | CID006918852 | |
| Drug | LG 5 | 7.00e-06 | 60 | 101 | 5 | CID011840957 | |
| Drug | probucol | 7.96e-06 | 162 | 101 | 7 | CID000004912 | |
| Drug | AC1L1C2F | 9.68e-06 | 110 | 101 | 6 | CID000001711 | |
| Drug | Rgd Peptide | 1.14e-05 | 239 | 101 | 8 | CID000104802 | |
| Drug | pitavastatin | 1.19e-05 | 114 | 101 | 6 | CID005282451 | |
| Drug | dysprosium | 1.96e-05 | 74 | 101 | 5 | CID000023912 | |
| Drug | 2-amino-5-methylpyridine | 2.38e-05 | 77 | 101 | 5 | CID000015348 | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.56e-05 | 194 | 101 | 7 | 4422_DN | |
| Drug | YIGSR | 2.70e-05 | 79 | 101 | 5 | CID000123977 | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 6873_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 3994_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 2.82e-05 | 197 | 101 | 7 | 1941_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 6623_DN | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 200 | 101 | 7 | 3886_UP | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.43e-05 | 83 | 101 | 5 | CID011968896 | |
| Drug | lead stearate | 3.64e-05 | 84 | 101 | 5 | CID000061258 | |
| Drug | NSC 714187 | 3.85e-05 | 85 | 101 | 5 | CID005288693 | |
| Drug | meprobamate | 4.55e-05 | 88 | 101 | 5 | CID000004064 | |
| Drug | ezetimibe | 5.01e-05 | 147 | 101 | 6 | CID000150311 | |
| Drug | H-9 dihydrochloride | 5.07e-05 | 90 | 101 | 5 | CID000003544 | |
| Drug | AC1L4UUJ | 6.59e-05 | 18 | 101 | 3 | CID000164475 | |
| Drug | AC1L1GUQ | 7.18e-05 | 50 | 101 | 4 | CID000003849 | |
| Drug | 25-hydroxycholesterol | 8.01e-05 | 160 | 101 | 6 | CID000065094 | |
| Drug | AC1L1EPA | 1.16e-04 | 4 | 101 | 2 | CID000028140 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.02e-06 | 53 | 100 | 5 | C4707243 | |
| Disease | cortical thickness | COL4A2 CDKN3 CRIM1 LAMA1 LAMA2 LAMC3 ADAM10 PLEKHM1 NELL1 THBS3 FBN2 JAG1 CPEB4 LRP1 LRP4 | 5.11e-06 | 1113 | 100 | 15 | EFO_0004840 |
| Disease | COVID-19 symptoms measurement | 6.00e-06 | 35 | 100 | 4 | EFO_0600019 | |
| Disease | response to cisplatin, platinum measurement | 3.20e-05 | 53 | 100 | 4 | EFO_0010154, GO_0072718 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | breast cancer, COVID-19 | 5.55e-05 | 22 | 100 | 3 | MONDO_0007254, MONDO_0100096 | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.75e-05 | 64 | 100 | 4 | DOID:4947 (is_marker_for) | |
| Disease | FEV/FEC ratio | COL4A2 CRIM1 TRA2B ZNF165 ANKS1B THBS3 FCGBP MEGF6 CPEB4 LRP1 LTBP1 LTBP2 TRMT61B ARAP1 | 6.79e-05 | 1228 | 100 | 14 | EFO_0004713 |
| Disease | Carcinoma, Pancreatic Ductal | 7.26e-05 | 24 | 100 | 3 | C0887833 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.13e-04 | 5 | 100 | 2 | DOID:3030 (is_marker_for) | |
| Disease | fear of minor pain measurement | 1.58e-04 | 31 | 100 | 3 | EFO_0008340 | |
| Disease | cortical surface area measurement | CDKN3 ZAN LRRC69 LAMA2 LAMC3 PLEKHM1 NELL1 FBN2 MEGF6 JAG1 CPEB4 FKBPL MNAT1 FBN3 | 1.76e-04 | 1345 | 100 | 14 | EFO_0010736 |
| Disease | urate measurement | TRIM46 MPV17 PHF7 ARHGEF25 THBS3 NRXN1 NISCH JAG1 CPEB4 LRP1 LRP4 | 2.28e-04 | 895 | 100 | 11 | EFO_0004531 |
| Disease | endometrial cancer (is_marker_for) | 2.28e-04 | 35 | 100 | 3 | DOID:1380 (is_marker_for) | |
| Disease | cancer antigen 15.3 measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0010585 | |
| Disease | temporal arteritis (is_marker_for) | 2.36e-04 | 7 | 100 | 2 | DOID:13375 (is_marker_for) | |
| Disease | Scoliosis, unspecified | 3.14e-04 | 8 | 100 | 2 | C0036439 | |
| Disease | complex trait | 3.29e-04 | 271 | 100 | 6 | EFO_0010578 | |
| Disease | hemangiopericytoma (is_marker_for) | 4.03e-04 | 9 | 100 | 2 | DOID:264 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 4.03e-04 | 9 | 100 | 2 | EFO_0009824 | |
| Disease | octadecanedioate measurement | 5.03e-04 | 10 | 100 | 2 | EFO_0021056 | |
| Disease | pulmonary fibrosis | 6.13e-04 | 11 | 100 | 2 | EFO_0009448 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 6.59e-04 | 50 | 100 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 8.66e-04 | 13 | 100 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.01e-03 | 14 | 100 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | LAMA2 PHF7 DLL1 ADAM10 THBS3 NISCH JAG1 TENM1 FKBPL NOTCH1 NOTCH4 | 1.04e-03 | 1074 | 100 | 11 | C0006142 |
| Disease | body weight | EPHA6 CRIM1 ANKS1B LRP1B NELL1 FBN2 NRXN1 CPEB4 CNTNAP4 LTBP1 LTBP2 ARAP1 | 1.15e-03 | 1261 | 100 | 12 | EFO_0004338 |
| Disease | migraine disorder | 1.38e-03 | 357 | 100 | 6 | MONDO_0005277 | |
| Disease | interstitial lung disease | 1.55e-03 | 67 | 100 | 3 | EFO_0004244 | |
| Disease | Alzheimer disease, educational attainment | 1.56e-03 | 247 | 100 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | colorectal cancer, colorectal adenoma | 1.81e-03 | 152 | 100 | 4 | EFO_0005406, MONDO_0005575 | |
| Disease | creatinine measurement | TRIM46 COL4A2 LAMA2 LAMA5 PHF7 LDLR NELL1 THBS3 CELSR3 MEGF10 | 2.03e-03 | 995 | 100 | 10 | EFO_0004518 |
| Disease | Mammary Carcinoma, Human | 2.09e-03 | 525 | 100 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.09e-03 | 525 | 100 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.14e-03 | 527 | 100 | 7 | C1458155 | |
| Disease | epilepsy (implicated_via_orthology) | 2.33e-03 | 163 | 100 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 2.40e-03 | 538 | 100 | 7 | C0678222 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.57e-03 | 80 | 100 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | response to radiation, Hematuria | 2.75e-03 | 23 | 100 | 2 | GO_0009314, HP_0000790 | |
| Disease | Myasthenic Syndromes, Congenital | 2.99e-03 | 24 | 100 | 2 | C0751882 | |
| Disease | congenital heart disease (is_implicated_in) | 2.99e-03 | 24 | 100 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | temperament and character inventory | 2.99e-03 | 24 | 100 | 2 | EFO_0004825 | |
| Disease | serum iron measurement | 3.15e-03 | 86 | 100 | 3 | EFO_0006332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLQEFLDPLCQRGFC | 951 | P55196 | |
| CQNERFGGCGSVLNI | 126 | Q7Z6V5 | |
| CLGLEGNLQGDPCRF | 416 | Q86VW2 | |
| ERVCSGPFFGGAACQ | 546 | O14514 | |
| AREGICNGFTALCPA | 531 | O14672 | |
| RATPFIECNGGRGTC | 1651 | P08572 | |
| NGGKCRERPIGFFCD | 971 | Q9C0A0 | |
| QNLEGSFRCICPPGF | 1946 | Q75N90 | |
| NTLGGFRCVCPSGFD | 2586 | Q75N90 | |
| NQTCGLCGDFNGLPA | 201 | Q9HC84 | |
| SGNRICRFAPGACDG | 91 | Q6ZNQ3 | |
| CRFAPGACDGLQNLI | 96 | Q6ZNQ3 | |
| EALTPCNGCRNLGFP | 406 | Q7Z6G8 | |
| FTGALCNEVCPSGRF | 651 | Q96KG7 | |
| EGGCGFCNQDRRTLP | 276 | O60568 | |
| ARASQDPLCGLCGNF | 991 | Q6W4X9 | |
| PIFLGIQGGSRCLAC | 56 | Q8WWZ1 | |
| IGRFRCNGFEDCPDG | 86 | Q86YD5 | |
| INTAFCDCLPGFRGT | 926 | P46531 | |
| RFQCGTGLCALPAFI | 3361 | Q9NZR2 | |
| DLLFVRGAGNCPECG | 36 | P51948 | |
| CIPGIFRCNGQDNCG | 3426 | Q07954 | |
| PGFLGDRCQYRQCSG | 4296 | Q07954 | |
| LCGPQGECLNTEGSF | 1211 | Q14766 | |
| LPACSQCGGQRIFEF | 286 | Q9BRP1 | |
| INCAAGNFLCPAGAL | 111 | Q9NUI1 | |
| LGDQGCFSEPQRCDG | 386 | O75074 | |
| PGVSGVRCDQCARGF | 1166 | P55268 | |
| VRCDQCARGFSGIFP | 1171 | P55268 | |
| AGINCETCTDGFFRP | 386 | P24043 | |
| GFIAQGCLVPGLCTF | 481 | A8MYU2 | |
| PKLRGQTCGLCGNFN | 561 | P98088 | |
| FAIGGLCNLCPDRAN | 76 | Q9H6L4 | |
| FGELCCGCLQLPGRQ | 656 | Q5JZY3 | |
| ASCERCAPGFFGNPL | 1946 | O15230 | |
| FCNGQIERGCEGPST | 1071 | Q9ULB1 | |
| FQCPRTSGFLCNDRG | 541 | P16144 | |
| FGFLGNVCNIPFLGA | 106 | Q6ZVE7 | |
| PGYVGNGTICRAFCE | 506 | Q92832 | |
| CRGLAIFFATCLQPG | 281 | Q5TF39 | |
| CGGPGNFCPSFSELQ | 181 | Q15646 | |
| CRCNFFQRLLGTEPG | 51 | C9JJ37 | |
| LAGLAQFCCRVQGTG | 11 | O95389 | |
| GSCCRVLALGFPFGS | 121 | Q9UIM3 | |
| QGARCGGKFAPFFCA | 531 | Q7Z5Q1 | |
| GTRCGGKFAPFFCAN | 641 | Q8NE35 | |
| ECARGYGGPNCQFLL | 506 | O00548 | |
| NGLLGCYPDRFGTCQ | 851 | Q9Y6R7 | |
| AEALCGLCGNFNGDP | 996 | Q9Y6R7 | |
| SPFRGRLCGLCGNFN | 4976 | Q9Y6R7 | |
| VGTCELANGARGFCP | 141 | Q6ZV77 | |
| GCTLNCPFGFLTDAQ | 511 | Q9NZV1 | |
| RGENFLCASGICIPG | 271 | Q9Y5Q5 | |
| FRCLCDQGFEISPSG | 1326 | Q14767 | |
| CFQGPEQGELLSPCR | 166 | Q9P2E8 | |
| VCQFLELCQSPEGGF | 126 | P49356 | |
| EDTCLCFNALGGLPG | 71 | Q9BY32 | |
| QGARCGGKFAPFFCA | 671 | Q17RY0 | |
| DGINRFSCLCPEGFA | 191 | Q6UY11 | |
| ELPGLCQGGNCINTF | 1656 | P35556 | |
| ICLFGSCTNTPGGFQ | 2066 | P35556 | |
| GALGRQCNSCDSPFA | 2101 | Q9NYQ7 | |
| PGSFRCQCEPGFQLG | 181 | O95967 | |
| RVNCSQFLGLCALPG | 36 | Q16667 | |
| DGFAPCQLCALGTFQ | 706 | Q9NQ36 | |
| EGPLFTCVFCRQGFL | 936 | Q9Y467 | |
| EGNPCFLDICGNFLV | 521 | Q96RY7 | |
| GSDGESIGNCPFCQR | 21 | O15247 | |
| CRPGNFCQQDFAGGD | 256 | O14772 | |
| NSIGCGFRPGNFSCV | 6 | P78385 | |
| NCPFCGARLGGFNFV | 86 | Q86T96 | |
| INRFQCLCPTGFSGN | 506 | P78504 | |
| TSQCEDCGGGLRFIP | 376 | Q9UF33 | |
| LGTDCNLTCPQGRFG | 1241 | O75095 | |
| NLDCRRGQFGPSCTL | 1461 | O75095 | |
| CAGCSRQIGFSFVRP | 831 | Q9Y4G2 | |
| PAFCFIGGGAVQLQE | 726 | Q7Z4K8 | |
| VGPFIGLFINTCGCR | 86 | Q7RTX9 | |
| FCVFLGRGAPGAACR | 181 | Q96AM1 | |
| LPCGQERGCLSQFFG | 121 | Q9BWX1 | |
| SNLIGGIFQCFPVSC | 386 | Q9BXS9 | |
| TAGQFRGGGVCINCL | 351 | P25391 | |
| GGVGPFQACGCRLVL | 26 | Q9NTG7 | |
| SDNAGFCIPEGNCLG | 306 | Q14108 | |
| FCIPEGNCLGSGVLN | 311 | Q14108 | |
| PGLCFGNGRCTLDQN | 766 | Q9UKZ4 | |
| LDQGGFAPCFLGCFL | 91 | P39210 | |
| LGQGTCQCAPGFLGE | 46 | Q99466 | |
| LRDFCSANPCVNGGV | 156 | Q99466 | |
| LLNGFQCICLPGFSG | 531 | Q99466 | |
| EAPELRGFFLGCGFN | 396 | Q9UL12 | |
| LGANTTLCQCPLGFF | 481 | Q8TER0 | |
| GQLRCFPQAFLPGCD | 136 | P13385 | |
| DGFNSCPDICFRVAG | 266 | Q969K4 | |
| LLGCGAGINCFSGDP | 681 | Q96P48 | |
| GLGQEPFEGARSLCC | 26 | Q9BVS5 | |
| EGRFGQSCQEQCPGI | 261 | P35590 | |
| GPFPCDICGRQFNDT | 516 | Q5SVQ8 | |
| FQLALCFGPAQLTGG | 36 | Q5VX71 | |
| CFGPAQLTGGFDDLQ | 41 | Q5VX71 | |
| GGCQERSQGCFPVYL | 846 | Q9Y2I1 | |
| VPLFLGSLFCAGCRQ | 71 | A1L4Q6 | |
| KCGPCRLGFLGNQSQ | 396 | P49746 | |
| FRCISRDCPGAGNNN | 21 | Q0VFX4 | |
| GERPFGCKECGRAFN | 396 | P49910 | |
| TGERPFPCTQCGQAF | 471 | Q5T619 | |
| LCGNRTDAGQCPEGY | 306 | Q01118 | |
| ACFGLQPGCLRQDGS | 426 | P52888 | |
| VFGLFGCFATCRGSP | 71 | P41732 | |
| RANPDPNCCLGVFGL | 111 | P62995 | |
| GQLRCFPQAFLPGCD | 136 | P51864 | |
| GERPFSCGQCQARFS | 196 | A8K8V0 | |
| REGCVCNPGFLFSDN | 1071 | Q9Y493 | |
| GDFSCGGRVNRCIPQ | 71 | P01130 | |
| GNLCDRCRPGTFNLQ | 456 | Q9Y6N6 | |
| QPLGFNKCGSRNGGC | 1306 | O75096 | |
| PFVCGDCGQGFVRSA | 411 | P28698 | |
| GEQPFRCAECGQSFR | 436 | P28698 |